resistant metastastic breast cancer have been published [5] . Three patients had partial remissions after autologous stem-cell transplant and complete remissions after allogeneic transplants; they achieved full chimerism and all developed graft-versushost disease before regression of cancer. All three are still alive at 82+, 87+ and 118+ months, one having relapsed at 67 months in the colon. Another patient showed no response to autologous stem-cell transplant but had partial remission after allografting. Five patients had grade II or higher acute graftversus-host disease and five had extensive chronic graftversus-host disease. No nonrelapse-related deaths occurred during the first 100 days.
In this article, we report a subsequent patient transplanted from her HLA-identical sister. Disappearance of liver, adrenal, mediastinal, pleural and diffuse nodes metastases observed simultaneously with clinical chronic Graft versus host disease (GVHD) 5 months after reduced intensity conditioning transplant suggest a profound graft-versus-tumor effect.
case report 2 /day on day 22). On day 0, 2.12 · 10 6 donor CD34 + cells/kg were infused. Immunosuppression was with methotrexate 8 mg/m 2 on days 1, 3 and 5 after transplantation, and cyclosporine 1 mg/kg/24 h from day 21 through day +15, subsequently 5 mg/kg orally. Sustained hematopoiesis was achieved on day +16 and the patient was discharged on day +17. Complete hematopoietic chimerism was documented 4 weeks after allografting by isoenzyme analysis in peripheral blood mononuclear cells. The further post-transplant course was uneventful until day +50 when acute graft-versus-host disease grade II of the skin developed. Treatment with methylprednisolone was started which was discontinued after graft-versus-host disease had resolved. On day +130, chronic graft-versus-host disease of the skin developed. One week later (20 April 2007), PET-CAT scan documented the total resolution of metastases in the liver, nodes, pleura, mediastinum and adrenal gland. Also bone metastases showed a significant reduction of PET positivity (Figures 1-3) . Nine months after Reduced-intensity conditioning for transplant (RICT), the patient is in complete remission under mild immunosuppressive treatment for limited Chronic graft versus host disease (cGVHD). 
